(Q81051738)
Statements
Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma (English)
Hiroshi Nakano
Tsunao Kishida
Masaharu Shin-Ya
Takashi Shinomiya
Jiro Imanishi
Taketoshi Shimada
Shigeru Nakai
Minoru Takeuchi
Yasuo Hisa
1 January 2006